PROS1 and myeloid sarcoma: Tables 3 and 4 also reports enrichment of autoantibodies targeting nucleic-acid binding proteins; the expression of autoantibodies to DNA/RNA and DNA/RNA-binding proteins is a common feature of autoimmune diseases. This result is consistent with previous demonstrations of sera from patients with MS being positive for antinuclear antibodies (39).